High school students from around the country learned about topics ranging from the neuropsychiatry of HIV to molecular genetics, forensic psychiatry, eating disorders, hoarding and virtual-reality therapeutics.
A new study reinforces the need for surgeons and physicians to monitor patients' use of painkillers following surgery and use alternative methods of pain control whenever possible.
Broken links between retinal ganglion cells and target structures throughout the brain spell permanent vision loss. But in a new study, these long-distance connections — and partial vision — were restored.
Patients with a group of cancers known as advanced systemic mastocytosis have few treatment options. A drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Latching chemotherapy drugs onto proteins that seek out tumors could provide an effective way of treating tumors in the brain or with limited blood supply.
New Stanford research resolves the debate on the link between canned food and exposure to the hormone-disrupting chemical known as Bisphenol A, or BPA.
Stanford engineers and doctors collaborated with industry to design a possible new treatment for lymphedema, which often affects cancer patients whose lymph nodes become blocked.
The designation is recognition of the Stanford Cancer Institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
A Stanford team has created a “nutrition surveillance” app that could help boost nutrition for children in some of the world’s poorest and most remote regions.
Edgar Arredondo has lived with a ventricular assist device for longer than any other patient being treated at Lucile Packard Children’s Hospital Stanford.
